Lee Ainslie Bio Techne Corp Call Options Transaction History
Maverick Capital LTD
- $4.82 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TECH
# of Institutions
598Shares Held
152MCall Options Held
195KPut Options Held
53.2K-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.32 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15MShares$1.08 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.42MShares$677 Million0.09% of portfolio
-
State Street Corp Boston, MA6.4MShares$459 Million0.02% of portfolio
-
Morgan Stanley New York, NY4.66MShares$335 Million0.03% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.82B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...